Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pseudomyxoma Peritonei × tislelizumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 5 Advanced Solid Tumor 4 Neoplasm Metastasis 3 Lung Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Simpson-Golabi-Behmel syndrome 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasm, Residual 1 Metastatic Solid Tumors 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Locally Advanced Rectal Cancer 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumour 1 Advanced Solid Tumors 1 Advanced Malignancies 1 Adenocarcinoma Of Esophagus 1

Interventions

cryoprecipitate coagulum 1 Specimen Handling 1 Nivolumab 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡